133156-06-6
Chemical Structure
GR-73632
- CAS No.: 133156-06-6
- Formula:C40H59N7O6S
- Molecular Weight:766.00
IUPAC Name: (S)-N-((S)-1-(((S)-1-amino-4-(methylthio)-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-1-((5-aminopentanoyl)-L-phenylalanyl-L-phenylalanyl)-N-methylpyrrolidine-2-carboxamide
InChIKey: HQKPTSSZOJLFBZ-LJADHVKFSA-N
SMILES: NCCCCC(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(N([C@@H](CC(C)C)C(N[C@H](C(N)=O)CCSC)=O)C)=O)=O)=O)=O
Biological Activity: GR-73632 is a tachykinin NK1 receptor agonist. GR-73632 activates spinal NK1 receptors to induce scratching, biting and licking behaviors. GR-73632 activates peripheral NK1 receptors to trigger lacrimation in guinea pigs, and activates central NK1 receptors to induce repetitive hind paw tapping behavior in gerbils. GR-73632 is applicable to research related to pruritus[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GR-73632 | 99.89% | GR-73632 is a tachykinin NK1 receptor agonist. GR-73632 activates spinal NK1 receptors to induce scratching, biting and licking behaviors. GR-73632 activates peripheral NK1 receptors to trigger lacrimation in guinea pigs, and activates central NK1 receptors to induce repetitive hind paw tapping behavior in gerbils. GR-73632 is applicable to research related to pruritus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Sakurada C, et al. Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist. Peptides. 1999;20(2):301-304. [Content Brief]
- [2]. Costantini VJ, et al. The NK1 receptor antagonist aprepitant attenuates NK1 agonist-induced scratching behaviour in the gerbil after intra-dermal, topical or oral administration. Exp Dermatol. 2015;24(4):312-314. [Content Brief]
- [3]. Bristow LJ, et al. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils. Eur J Pharmacol. 1994;253(3):245-252. [Content Brief]
Keywords
